These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections. Samonis G; Vardakas KZ; Kofteridis DP; Dimopoulou D; Andrianaki AM; Chatzinikolaou I; Katsanevaki E; Maraki S; Falagas ME Infection; 2014 Aug; 42(4):721-8. PubMed ID: 24912861 [TBL] [Abstract][Full Text] [Related]
5. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm. Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591 [TBL] [Abstract][Full Text] [Related]
6. Clinical impact of time-to-positivity of blood cultures on mortality in patients with Pseudomonas aeruginosa bacteremia. Rolo M; Martín-Higuera MC; Viedma E; Villa J; Mancheño-Losa M; Lora-Tamayo J; Chaves F; Orellana MÁ; Recio R J Glob Antimicrob Resist; 2022 Sep; 30():269-275. PubMed ID: 35787987 [TBL] [Abstract][Full Text] [Related]
7. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449 [TBL] [Abstract][Full Text] [Related]
8. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia. Ng TM; Teng CB; Lye DC; Apisarnthanarak A Infect Control Hosp Epidemiol; 2014 Jan; 35(1):49-55. PubMed ID: 24334798 [TBL] [Abstract][Full Text] [Related]
9. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis. Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530 [TBL] [Abstract][Full Text] [Related]
10. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A; Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria. Santoro A; Franceschini E; Meschiari M; Menozzi M; Zona S; Venturelli C; Digaetano M; Rogati C; Guaraldi G; Paul M; Gyssens IC; Mussini C Open Forum Infect Dis; 2020 Nov; 7(11):ofaa461. PubMed ID: 33209951 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia. Su TY; Ye JJ; Hsu PC; Wu HF; Chia JH; Lee MH J Microbiol Immunol Infect; 2015 Apr; 48(2):175-82. PubMed ID: 24064286 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa. Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW Microb Drug Resist; 2005; 11(1):68-74. PubMed ID: 15770098 [TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Prognosis of Bloodstream Infection with Carbapenem-Resistant Yuan F; Xiao W; Wang X; Fu Y; Wei X Infect Drug Resist; 2023; 16():4943-4952. PubMed ID: 37546370 [TBL] [Abstract][Full Text] [Related]
18. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Zaragoza R; Artero A; Camarena JJ; Sancho S; González R; Nogueira JM Clin Microbiol Infect; 2003 May; 9(5):412-8. PubMed ID: 12848754 [TBL] [Abstract][Full Text] [Related]
19. Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms. Saliba M; Saadeh D; Bouchand F; Davido B; Duran C; Clair B; Lawrence C; Annane D; Denys P; Salomon J; Bernard L; Dinh A Spinal Cord; 2017 Feb; 55(2):148-154. PubMed ID: 27995941 [TBL] [Abstract][Full Text] [Related]
20. [Effect of adequate initial antimicrobial therapy on mortality in critical patients with Pseudomonas aeruginosa bacteremia]. González AL; Leal AL; Cortés JA; Sánchez R; Barrero LI; Castillo JS; Álvarez CA Biomedica; 2014 Apr; 34 Suppl 1():58-66. PubMed ID: 24968037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]